Clinical implications of altered drug transporter abundance/function and PBPK modeling in specific populations: an ITC perspective

X Chu, B Prasad, S Neuhoff, K Yoshida… - Clinical …, 2022 - Wiley Online Library
The role of membrane transporters on pharmacokinetics (PKs), drug–drug interactions
(DDIs), pharmacodynamics (PDs), and toxicity of drugs has been broadly recognized …
被引用次数：29 相关文章

Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective.

X Chu, B Prasad, S Neuhoff… - Clinical …, 2022 - scholarlyexchange.childrensmercy …
The role of membrane transporters on pharmacokinetics (PKs), drug-drug interactions
(DDIs), pharmacodynamics (PDs), and toxicity of drugs has been broadly recognized …
[PDF] manchester.ac.uk

[PDF][PDF] Clinical implications of altered drug transporter abundance/function and PBPK modeling in specific populations: An ITC perspective

X Chu, B Prasad, S Neuhoff, K Yoshida, JS Leeder… - pure.manchester.ac.uk
The role of membrane transporters on pharmacokinetics (PK), drug-drug interactions (DDIs),
pharmacodynamics (PD), and toxicity of drugs has been broadly recognized. However, our …

Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective

X Chu, B Prasad, S Neuhoff… - Clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
The role of membrane transporters on pharmacokinetics (PKs), drug-drug interactions
(DDIs), pharmacodynamics (PDs), and toxicity of drugs has been broadly recognized …

Clinical implications of altered drug transporter abundance/function and PBPK modeling in specific populations: An ITC perspective

X Chu, B Prasad, S Neuhoff… - Clinical …, 2022 - research.manchester.ac.uk
The role of membrane transporters on pharmacokinetics (PK), drug-drug interactions (DDIs),
pharmacodynamics (PD), and toxicity of drugs has been broadly recognized. However, our …

Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective.

X Chu, B Prasad, S Neuhoff, K Yoshida… - Clinical …, 2022 - europepmc.org
The role of membrane transporters on pharmacokinetics (PKs), drug-drug interactions
(DDIs), pharmacodynamics (PDs), and toxicity of drugs has been broadly recognized …